Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, mortality and deterioration in kidney function in patients with type 2 diabetes

Publikation: KonferencebidragKonferenceabstrakt til konferenceForskning

  1. 53rd Annual Meeting of the European Association for the study of Diabetes EASD

    Aktivitet: Deltagelse i eller arrangering af en begivenhedOrganisation af og deltagelse i konference

  1. Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart Failure

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. A large remaining potential in lipid-lowering drug treatment in the type 2 diabetes population: A Danish nationwide cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
OriginalsprogEngelsk
Publikationsdato12 sep. 2017
Antal sider1
StatusUdgivet - 12 sep. 2017
Begivenhed53rd Annual Meeting of the European Association for the study of Diabetes EASD - International Fair of Lisbon and MEO Arena, Rua do Bojador, Parque das Nações, Lisabon, Portugal
Varighed: 11 sep. 201715 sep. 2017
https://www.easd.org/annual-meeting/easd-2017.html

Konference

Konference53rd Annual Meeting of the European Association for the study of Diabetes EASD
LokationInternational Fair of Lisbon and MEO Arena, Rua do Bojador, Parque das Nações
LandPortugal
ByLisabon
Periode11/09/201715/09/2017
Internetadresse

Begivenhed

53rd Annual Meeting of the European Association for the study of Diabetes EASD

11/09/201715/09/2017

Lisabon, Portugal

Begivenhed: Konference

ID: 52090016